Clinical trial
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
NCT00002070 is registered in ClinicalTrials.gov with Schering-Plough as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
- Lead sponsor
- Schering-Plough
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.